T cell exhaustion
- PMID: 21739672
- DOI: 10.1038/ni.2035
T cell exhaustion
Abstract
T cell exhaustion is a state of T cell dysfunction that arises during many chronic infections and cancer. It is defined by poor effector function, sustained expression of inhibitory receptors and a transcriptional state distinct from that of functional effector or memory T cells. Exhaustion prevents optimal control of infection and tumors. Recently, a clearer picture of the functional and phenotypic profile of exhausted T cells has emerged and T cell exhaustion has been defined in many experimental and clinical settings. Although the pathways involved remain to be fully defined, advances in the molecular delineation of T cell exhaustion are clarifying the underlying causes of this state of differentiation and also suggest promising therapeutic opportunities.
Similar articles
-
Transcription factor regulation of CD8+ T-cell memory and exhaustion.Immunol Rev. 2010 Jul;236:167-75. doi: 10.1111/j.1600-065X.2010.00927.x. Immunol Rev. 2010. PMID: 20636816 Review.
-
Molecular and cellular insights into T cell exhaustion.Nat Rev Immunol. 2015 Aug;15(8):486-99. doi: 10.1038/nri3862. Nat Rev Immunol. 2015. PMID: 26205583 Free PMC article. Review.
-
Understand memory, design better vaccines.Nat Immunol. 2011 Jun;12(6):463-5. doi: 10.1038/ni.2041. Nat Immunol. 2011. PMID: 21587308 Free PMC article.
-
Heterogeneity and fate choice: T cell exhaustion in cancer and chronic infections.Curr Opin Immunol. 2019 Jun;58:98-103. doi: 10.1016/j.coi.2019.04.014. Epub 2019 Jun 8. Curr Opin Immunol. 2019. PMID: 31181510 Free PMC article. Review.
-
Exhausted CD8 T cells downregulate the IL-18 receptor and become unresponsive to inflammatory cytokines and bacterial co-infections.PLoS Pathog. 2011 Sep;7(9):e1002273. doi: 10.1371/journal.ppat.1002273. Epub 2011 Sep 29. PLoS Pathog. 2011. PMID: 21980291 Free PMC article.
Cited by
-
Overcoming Antigen Escape and T-Cell Exhaustion in CAR-T Therapy for Leukemia.Cells. 2024 Sep 23;13(18):1596. doi: 10.3390/cells13181596. Cells. 2024. PMID: 39329777 Free PMC article. Review.
-
Recent advancements in improving the efficacy and safety of chimeric antigen receptor (CAR)-T cell therapy for hepatocellular carcinoma.Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep 24. doi: 10.1007/s00210-024-03443-7. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 39316087 Review.
-
Single-cell RNA sequencing reveals intratumoral heterogeneity and multicellular community in primary hepatocellular carcinoma underlying microvascular invasion.Heliyon. 2024 Aug 31;10(18):e37233. doi: 10.1016/j.heliyon.2024.e37233. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39309949 Free PMC article.
-
Deficiency and dysfunctional roles of natural killer T cells in patients with ARDS.Front Immunol. 2024 Aug 30;15:1433028. doi: 10.3389/fimmu.2024.1433028. eCollection 2024. Front Immunol. 2024. PMID: 39281681 Free PMC article.
-
The Significance of Longitudinal Psoas Muscle Loss in Predicting the Maintenance Efficacy of Durvalumab Treatment Following Concurrent Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer: A Retrospective Study.Cancers (Basel). 2024 Aug 30;16(17):3037. doi: 10.3390/cancers16173037. Cancers (Basel). 2024. PMID: 39272894 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources